BALFRON PODIATRY CLINIC LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (71/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-09-13 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
Corporate timeline (5 events)Click to expand
- 2025-09-14📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-09-14📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-09-08🏢Company incorporatedAs BALFRON PODIATRY CLINIC LTD
- 2024-09-08➕MALLEY, Jennifer appointeddirector
- 2024-09-08📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.6 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Jennifer Malley Individual · British · DOB 08/1982 · age 44 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 08/09/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ARDPEATON LIMITED→ SC780810 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ARRAN PHARMACY LIMITED→ SC222920 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| ASHPHARM GLASGOW LTD→ SC628555 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AVISTAR MEDICAL LTD→ SC864683 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AYR CARE LTD→ SC665188 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| BABY SCAN STUDIOS LTD→ SC535327 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| BAKHSH FOUNDATION→ SC387737 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| BALMORE CLINIC LTD→ SC494943 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| BALMORE EYECARE LIMITED→ SC766779 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| BARBOSA LIMITED→ SC443555 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| BARNES CHIROPRACTIC LTD.→ SC429849 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| BARNTON DENTAL SPA LIMITED→ SC564511 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.